控缓释制剂治疗肝癌新进展
被引量：3
Advances in controlled-and sustained-release drugs for the therapy of liver cancer
摘要
控缓释制剂是一种新型药物剂型,与传统药物相比,达到了增效减毒的目的,对毒性大的抗肿瘤药意义非凡。近年来在肝癌研究方面取得了令人鼓舞的成果,拓宽了肝癌治疗尤其是化疗的思路。控缓释制剂包括多种形态,可经多途径给药应用于肝癌治疗。
出处
《国外医学（肿瘤学分册）》
CAS
2005年第12期933-936,共4页
Foreign Medical Sciences (Cancer Section)
参考文献19
-
1Abe S, Otsuki M. Styrene maleic acid neocarzinostatin treatment for hepatocellular carcinoma. Curr Med Chem Anti-Canc Agents,2002,2(6) :715-726.
-
2Kishimoto S, Miyazawa K, Fukushima S, et al. In vitro antitumor activity,intracellular accumulation, and DNA adduct formation of cis-[ ( (1R,2R)-1,2-cyclohexanediamine-n, n') bis ( myristato ) ] platinum(Ⅱ) suspended in lipiodol. Jpn J Cancer Res, 2000,91 (1) :99-104.
-
3Okusaka T, Okada S, Nakanishi T, et al. Phase Ⅱ trial of intra-arterial chemotherapy using a novel lipophilic platinum derivative (SM-11555 ) in patients with hepatocellular carcinoma. Invest New Drugs,2004,22(2) :169-176.
-
4Pourgholami MH, Akhter J, Finlay IG, et al. 1,25-dihydroxyvitamin D3 dissolved in lipiodol produces a sustained antiproliferative effect in the human hepatoblastoma cell line HepG2. Anticancer Res, 2000,20(2A) :723-727.
-
5Morris DL, Jourdan JL, Finlay I, et al. Hepatic intra-arterial injection of 1,25-dihydroxyvitamin D3 in lipiodol: Pilot study in patients with hepatocellular carcinoma. Int J Oncol, 2002,21 (4) :901-906.
-
6Mok TS, Kanekal S, Lin XR, et al. Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma. Cancer,2000,91 (12) :2369-2377.
-
7Leung TW, Yu S, Johnson PJ, et al. Phase Ⅱ study of the efficacy and safety of cisplatin-epinephrine injectable gel administered to patients with unresectable hepatocellular carcinoma. J Clin Oncol,2003,21 (4) :652-658.
-
8Vogl TJ, Engelmann K, Mack MG, et al. CT-guided intratumoural administration of cisplatin/epinephrine gel for treatment of malignant liver tumours. Br J Cancer, 2002,86(4) :524-529.
-
9Hanes J, Sills A, Zhao Z, et al. Controlled local delivery of interleukin-2 by biodegradable polymers protects animals from experimental brain tumors and liver tumors. Pharm Res, 2001,18 (7) :899-906.
-
10Guerin C, Olivi A, Weingart JD, et al. Recent advances in brain tumor therapy: local intracerebral drug delivery by polymers. Invest New Drugs, 2004,22( 1 ) :27-57.
同被引文献39
-
1吴孟超,吴东.原发性肝癌综合治疗的现状与展望[J].癌症进展,2005,3(5):410-412. 被引量：30
-
2王帆,周石.肝动脉化疗栓塞联合氩氦刀治疗原发性肝癌疗效评价[J].介入放射学杂志,2005,14(6):637-639. 被引量：13
-
3张树民,曾昭冲,汤钊猷,潘銮凤,薛琼,陈杰,孙瑞霞.咖啡因促受照射肝癌细胞株MHCC97H凋亡的实验研究[J].实用肿瘤杂志,2007,22(1):23-27. 被引量：11
-
4Choi B I Kim HC,Han JK et aI.Therapeutic effect of transcatheter oilychemoembolizatiion therpy for emcapsulated nodular hepatocellular carcinoma: CT and pathlotogic findings [J]. Radiology, 1992m182 (3) : 709-713.
-
5Staunton M Dodd JD,Mocormick PA,et aI,Finding evidencebased answers to practical question in radiology:which patients with inoperable hapatocellular carcinoma will survive longer aftertransarterial chemoembolizatiion Radiology, 2005 237 : 404-413.
-
6Okuda K,Ohtsuk T,Obata H et aI.Natural history of hepatocellular carcinoma and prognosis in relation to treatment;study of 850 patients. Cancer 1985 56.9 8-928.
-
7Okadas. Transcatheter arterial embolization for advanced hepatocellular carcinoma: The controversy continues. Hepatology , 1998 27:1743-1744.
-
8刘廷洲,苑桂平,高金玲,刘绪胜,邵元伟.原发性肝癌双介入治疗疗效的临床研究[J].实用医学影像杂志,2007,8(5):322-324. 被引量：4
-
9曾昭冲.腹部肿瘤的放射治疗—— 肝细胞癌的放射治疗[J].实用肿瘤杂志,2007,22(5):380-384. 被引量：12
-
10Snariff MI,Cox IJ, Gomaa AL,et al. Hepatocevllular carcinoma:curruent trendes in Wordwide epidemiology,risk factors,diagno-sis ande therapeutics [J]. Expert Rev Gastroenterol Hepatol,2009,3(4) :353-367.
引证文献3
-
1郭青,董方晓,栾翠美,颜玉茂.TACE联合缓释化疗粒子(5-Fu)治疗原发性肝癌的临床研究[J].当代医学,2010,16(17):302-304. 被引量：4
-
2李国文,郭贵海.TACE在原发性肝癌中的应用现状与进展研究[J].江西医药,2012,47(12):1109-1111. 被引量：7
-
3徐志巧,刘培杰,张燕,高岭,李宁,帖晓静,弋振营,高欣.原发性肝癌瘤体植入缓释顺铂同步联合精确放疗的疗效分析[J].医药论坛杂志,2014,35(2):28-31.
二级引证文献11
-
1潘彦康,黄敏,刘裕恒.抗肿瘤缓释剂在肝癌介入治疗中的应用[J].中国组织工程研究与临床康复,2011,15(38):7197-7200.
-
2李国文,郭贵海.TACE在原发性肝癌中的应用现状与进展研究[J].江西医药,2012,47(12):1109-1111. 被引量：7
-
3田浪,胡勇,彭俊平.局部植入缓释化疗药物治疗腹部肿瘤的研究进展[J].肿瘤预防与治疗,2013,26(4):251-253. 被引量：3
-
4莫红梅,柴晓玮,玄祖旗.肝癌切除术联合TACE对原发性肝癌患者细胞免疫和调节性T淋巴细胞的影响[J].国际检验医学杂志,2013,34(21):2825-2826. 被引量：5
-
5李顺,张桂敏.预防介入治疗术后肝癌患者恶心、呕吐的护理进展[J].解放军护理杂志,2013,30(19):28-30. 被引量：11
-
6邱金宝,李庆萍,周瑜.高强度聚焦超声治疗联合肝动脉栓塞化疗对肝癌伴门静脉癌栓患者生存的影响[J].江西医药,2013,48(12):1174-1176. 被引量：5
-
7郭晓光,王虎明.替吉奥联合TACE序贯肝动脉灌注奥沙利铂治疗转移性肝癌的临床研究[J].中国临床研究,2015,28(5):559-562. 被引量：7
-
8程文元,戴振华,楼丽霞,丰云峰.经皮肝瘤内注射术联合经导管肝动脉化疗栓塞术治疗中晚期肝癌的临床研究[J].中国基层医药,2015,22(15):2247-2250. 被引量：6
-
9李雪荣,宋亚华,李婵,杨会,郭晓燕.综合护理干预在原发性肝癌肝动脉化疗栓塞术中的效果观察[J].中国煤炭工业医学杂志,2016,18(5):756-759. 被引量：23
-
10曾世彬,饶晓军,梅浪华,龙剑,查国华.前列地尔联合异甘草酸镁治疗肝癌TACE术后肝功能异常临床观察[J].江西医药,2017,52(1):50-52. 被引量：3
-
1李君凤,石善良.美菲康治疗癌痛80例分析[J].中国误诊学杂志,2007,7(5):1064-1065. 被引量：1
-
2王成锋,赵平,单毅,赵东兵,田艳涛,白晓枫,孙跃民,车旭,曲辉,解亦斌.5-氟尿嘧啶缓释剂植入治疗局部进展期胰腺癌[J].中华肿瘤杂志,2010,32(9):706-708. 被引量：14
-
3尹震.脑胶质瘤局部缓释药物间质化疗的研究进展[J].空军总医院学报,1999,15(1):21-23.
-
4杨明鲜,刘月娥,张丽琴.卵巢癌多途径化疗69例临床分析[J].山西职工医学院学报,2003,13(1):16-17.
-
5李井泉,王世亮,丁满志,陈殿良,祝牡丹,蒲永东.胰腺癌间质化疗临床疗效分析[J].中国全科医学,2012,15(32):3789-3791. 被引量：4
-
6陈黎,王争,陈锦先.术中使用缓释型5-FU对于进展期结肠癌的疗效研究[J].外科理论与实践,2007,12(5):499-501. 被引量：13
-
7金仲品,王风秀.紫杉醇抗肿瘤的临床研究进展[J].滨州职业学院学报,2008,0(3):24-27. 被引量：5
-
8江洪,周星明,严福来,陈奇勋.食管癌术中植入5-氟尿嘧啶缓释剂的安全性[J].中国肿瘤,2006,15(4):262-264. 被引量：10
-
9罗奕.硫酸吗啡控释片用于癌症镇痛68例疗效观察[J].医学临床研究,2003,20(12):953-955.
-
10左丽,李安琪,江联萍,陶莉,郑鸿,王妹兴,李纲.盐酸羟考酮缓释片治疗中重度癌痛临床观察[J].实用肿瘤杂志,2015,30(1):85-87. 被引量：19
